1 |
Rao K, Malani PN. Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020[J]. JAMA, 2020, 323(14): 1403-4.
|
2 |
Heinlen L, Ballard JD. Clostridium difficile infection[J]. Am J Med Sci, 2010, 340(3): 247-52.
|
3 |
Knight DR, Elliott B, Chang BJ, et al. Diversity and Evolution in the Genome of Clostridium difficile [J]. Clin Microbiol Rev, 2015, 28(3): 721-41.
|
4 |
The United States Centers for Disease Control and Prevention.2019 AR Threats Report. .
|
5 |
Suo JJ, Yan ZQ, Wu Y, et al. Clostridium difficile RT 078/ST11: a Threat to Community Population and Pigs Identified in Elder Hospitalized Patients in Beijing, China[J]. Infect Control Hosp Epidemiol, 2017, 38(11): 1383-5.
|
6 |
Jia HB, Du PC, Yang H, et al. Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012–2014, traced by whole genome sequencing[J]. BMC Genom, 2016, 17(1): 405.
|
7 |
Lv Z, Peng GL, Su JR. Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China[J]. Braz J Med Biol Res, 2014, 47(12): 1085-90.
|
8 |
吴 媛, 李文革, 贾筱溪, 等. 我国艰难梭菌流行特征和研究进展[J]. 疾病监测, 2021, 36(4): 319-23.
|
9 |
Bélanger SD, Boissinot M, Clairoux N, et al. Rapid detection of Clostridium difficile in feces by real-time PCR[J]. J Clin Microbiol, 2003, 41(2): 730-4.
|
10 |
谢 群, 李 军, 吴 媛, 等. 郴州市住院腹泻患者艰难梭菌感染状况及其基因特征[J]. 中华医院感染学杂志, 2022, 32(9): 1303-6.
|
11 |
Mansour NM, Elkhatib WF, Aboshanab KM, et al. Inhibition of Clostridium difficile in Mice Using a Mixture of Potential Probiotic Strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel Candidates to Control C. difficile Infection (CDI)[J]. Probiotics Antimicrob Proteins, 2018, 10(3): 511-22.
|
12 |
Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile [J]. J Clin Microbiol, 2010, 48(3): 770-8.
|
13 |
Zhang WZ, Li WG, Liu YQ, et al. The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China[J]. BMC Microbiol, 2020, 20(1): 70.
|
14 |
Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections[J]. N Engl J Med, 2014, 370(13): 1198-208.
|
15 |
Zhang XX, Wang XH, Yang JY, et al. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study[J]. BMC Infect Dis, 2016, 16: 397.
|
16 |
李 洋, 姚立琼, 刘志武, 等. 艰难梭菌毒素基因检测及分子流行病学分析[J]. 临床检验杂志, 2020, 38(6): 431-3.
|
17 |
Tang CJ, Cui LB, Xu YQ, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland: a systematic review and meta-analysis[J]. Sci Rep, 2016, 6: 37865.
|
18 |
Liu XS, Li WG, Zhang WZ, et al. Molecular Characterization of Clostridium difficile Isolates in China From 2010 to 2015[J]. Front Microbiol, 2018, 9: 845.
|
19 |
Jin DZ, Luo Y, Huang C, et al. Molecular epidemiology of Clostridium difficile infection in hospitalized patients in eastern China[J]. J Clin Microbiol, 2017, 55(3): 801-10.
|
20 |
Martínez-Meléndez A, Cruz-López F, Morfin-Otero R, et al. An update on Clostridioides difficile binary toxin[J]. Toxins, 2022, 14(5): 305.
|
21 |
Xu QM, Chen YB, Gu SL, et al. Hospital-acquired Clostridium difficile infection in Mainland China: a seven-year (2009-2016) retrospective study in a large university hospital[J]. Sci Rep, 2017, 7(1): 9645.
|
22 |
Tian TT, Zhao JH, Yang J, et al. Molecular characterization of Clostridium difficile isolates from human subjects and the environment[J]. PLoS One, 2016, 11(3): e0151964.
|
23 |
Cheng JW, Xiao M, Kudinha T, et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from a university teaching hospital in China[J]. Front Microbiol, 2016, 7: 1621.
|
24 |
Ziakas PD, Zacharioudakis IM, Zervou FN, et al. Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: a Meta-Analysis of Prevalence and Risk Factors[J]. PLoS One, 2015, 10(2): e0117195.
|
25 |
Truong C, Schroeder LF, Gaur R, et al. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing[J]. Diagn Microbiol Infect Dis, 2017, 87(4): 365-70.
|
26 |
刘俊枫, 李 刚, 臧一铭, 等. 宁夏地区临床腹泻患者艰难梭菌感染及危险因素[J]. 中华医院感染学杂志, 2022, 32(24): 3687-91.
|
27 |
Zhang J, Chen L, Gomez-Simmonds A, et al. Antibiotic-specific risk for community-acquired Clostridioides difficile infection in the United States from 2008 to 2020[J]. Antimicrob Agents Chemother, 2022, 66(12): e0112922.
|
28 |
Migriauli I, Meunargia V, Chkhaidze I, et al. Clostridium difficile infection in children with exposure to antibiotics[J]. Georgian Med News, 2019(288): 48-54.
|
29 |
Hung YP, Lee JC, Tsai BY, et al. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: vary by hospitalized duration[J]. J Microbiol Immunol Infect, 2021, 54(2): 276-83.
|
30 |
Abdelsattar ZM, Krapohl G, Alrahmani L, et al. Postoperative burden of hospital-acquired Clostridium difficile infection[J]. Infect Control Hosp Epidemiol, 2015, 36(1): 40-6.
|
31 |
Kim J, Kim Y, Pai H. Clinical characteristics and treatment outcomes of Clostridium difficile infections by PCR ribotype 017 and 018 strains[J]. PLoS One, 2016, 11(12): e0168849.
|
32 |
Donskey CJ. Clostridium difficile in older adults[J]. Infect Dis Clin North Am, 2017, 31(4): 743-56.
|